Cleveland Clinic's 20th Annual ASH Review
2019 ASH Review on MDS: Luspatercept Under FDA Review, Novel Oral HMT Are Emerging and May Become Basis of New Backbone Therapy for Pts With MDS and AML
Login to view comments.
Click here to Login